2021
DOI: 10.1080/14760584.2021.1932475
View full text
|
|

Abstract: Introduction : The ongoing SARS-CoV-2 pandemic is a serious threat for the health of immunocompromised patients. Among neutralizing antibody-based therapeutics, convalescent plasma containing polyclonal anti-SARS-CoV-2 immunoglobulins has promising results in both congenital and iatrogenic immunodeficiencies in oncohematological and transplant patients. Areas covered : This article discusses case reports, case series and controlled studies detailing the eff… Show more

Help me understand this page

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
6
0

Publication Types

Select...

Relationship

0
0

Authors

Journals